Literature DB >> 22331083

[Is pregnancy-related facial nerve paresis a separate disease entity?].

O Guntinas-Lichius1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22331083     DOI： 10.1007/s00106-011-2449-y

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  7 in total

1.  [Idiopathic facial palsy].

Authors:  M Grosheva; D Beutner; G F Volk; C Wittekindt; O Guntinas-Lichius
Journal:  HNO       Date:  2010-05       Impact factor: 1.284

Review 2.  Clinical practice. Bell's Palsy.

Authors:  Donald H Gilden
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 3.  Corticosteroids for Bell's palsy (idiopathic facial paralysis).

Authors:  Rodrigo A Salinas; Gonzalo Alvarez; Fergus Daly; Joaquim Ferreira
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

4.  Bell's palsy during pregnancy: is it associated with adverse perinatal outcome?

Authors:  Ariel Katz; Ruslan Sergienko; Uri Dior; Arnon Wiznitzer; Daniel M Kaplan; Eyal Sheiner
Journal:  Laryngoscope       Date:  2011-05-16       Impact factor: 3.325

5.  Prognostic value of electroneurography and electromyography in facial palsy.

Authors:  Maria Grosheva; Claus Wittekindt; Orlando Guntinas-Lichius
Journal:  Laryngoscope       Date:  2008-03       Impact factor: 3.325

Review 6.  Bell's palsy and pregnancy.

Authors:  Jeffrey T Vrabec; Brandon Isaacson; James W Van Hook
Journal:  Otolaryngol Head Neck Surg       Date:  2007-12       Impact factor: 3.497

7.  Significance of electromyography to predict and evaluate facial function outcome after acute peripheral facial palsy.

Authors:  Maria Grosheva; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-05       Impact factor: 2.503
  7 in total
  1 in total

1.  The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell's Palsy).

Authors:  Josef Georg Heckmann; Peter Paul Urban; Susanne Pitz; Orlando Guntinas-Lichius; Ildikό Gágyor
Journal:  Dtsch Arztebl Int       Date:  2019-10-11       Impact factor: 5.594
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.